Combigene (Sweden) Price on December 10, 2024
| COMBI Stock | SEK 2.60 0.06 2.26% |
If you're considering investing in Combigene Stock, it is important to understand the factors that can impact its price. As of today, the current price of Combigene stands at 2.60, as last reported on the 12th of December 2024, with the highest price reaching 2.76 and the lowest price hitting 2.48 during the day. Combigene appears to be extremely dangerous, given 3 months investment horizon. Combigene AB secures Sharpe Ratio (or Efficiency) of 0.0447, which signifies that the company had a 0.0447% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Combigene AB, which you can use to evaluate the volatility of the firm. Please makes use of Combigene's Mean Deviation of 4.52, downside deviation of 6.75, and Risk Adjusted Performance of 0.0398 to double-check if our risk estimates are consistent with your expectations.
Combigene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Combigene |
Sharpe Ratio = 0.0447
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | COMBI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.04 actual daily | 71 71% of assets are less volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Combigene is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Combigene by adding it to a well-diversified portfolio.
Combigene Valuation on December 10, 2024
It is possible to determine the worth of Combigene on a given historical date. On December 10, 2024 Combigene was worth 2.38 at the beginning of the trading date compared to the closed value of 2.66. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Combigene stock. Still, in general, we apply an absolute valuation method to find Combigene's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Combigene where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Combigene's related companies.
| Open | High | Low | Close | Volume | |
| 2.58 | 2.74 | 2.36 | 2.44 | 6,753 | |
12/10/2024 | 2.38 | 2.68 | 2.38 | 2.66 | 15,280 |
| 2.52 | 2.76 | 2.48 | 2.60 | 14,415 |
| Backtest Combigene | | | Combigene History | | | Combigene Valuation | Previous | Next |
Combigene Trading Date Momentum on December 10, 2024
| On December 11 2024 Combigene AB was traded for 2.60 at the closing time. The highest price during the trading period was 2.76 and the lowest recorded bid was listed for 2.48 . The volume for the day was 14.4 K. This history from December 11, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 2.26% . The overall trading delta to the current price is 5.26% . |
Combigene AB Fundamentals Correlations and Trends
By evaluating Combigene's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Combigene's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Combigene financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Combigene Stock history
Combigene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Combigene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Combigene AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Combigene stock prices may prove useful in developing a viable investing in Combigene
CombiGene AB engages in the development and commercialization of gene therapy for the treatment of neurological and psychiatric disorders. CombiGene AB was founded in 1999 and is headquartered in Lund, Sweden. Combigene operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 7 people.
Combigene Stock Technical Analysis
Combigene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Combigene Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Combigene AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Combigene December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Combigene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Combigene shares will generate the highest return on investment. By undertsting and applying Combigene stock market strength indicators, traders can identify Combigene AB entry and exit signals to maximize returns
Combigene Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Combigene's price direction in advance. Along with the technical and fundamental analysis of Combigene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Combigene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0398 | |||
| Jensen Alpha | 0.2846 | |||
| Total Risk Alpha | (0.93) | |||
| Sortino Ratio | 0.0315 | |||
| Treynor Ratio | 0.8882 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Combigene Stock Analysis
When running Combigene's price analysis, check to measure Combigene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Combigene is operating at the current time. Most of Combigene's value examination focuses on studying past and present price action to predict the probability of Combigene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Combigene's price. Additionally, you may evaluate how the addition of Combigene to your portfolios can decrease your overall portfolio volatility.